| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 670 |
| 1 | ACETAMINOPHEN | 368 |
| 2 | PREDNISONE | 345 |
| 3 | RITUXIMAB | 323 |
| 4 | ACETAMINOPHEN 500MG | 266 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 266 |
| 6 | PAIN RELIEVER | 266 |
| 7 | METHOTREXATE SODIUM | 261 |
| 8 | ADALIMUMAB | 257 |
| 9 | METHYLPREDNISOLONE | 252 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE VALERATE | 26 | 0.0414 |
| 1 | ONASEMNOGENE ABEPARVOVEC-XIOI | 42 | 0.0182 |
| 2 | TETRAHYDROZOLINE HYDROCHLORIDE | 3 | 0.0102 |
| 3 | LANOLIN, PETROLATUM | 2 | 0.0081 |
| 4 | PRAZOSIN HYDROCHLORIDE | 9 | 0.0065 |
| 5 | NALOXONE HCL | 5 | 0.0058 |
| 6 | TAGRAXOFUSP | 3 | 0.0056 |
| 7 | CLOZAPINE | 670 | 0.0053 |
| 8 | CORTISOL | 2 | 0.0050 |
| 9 | ALEMTUZUMAB | 95 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 819 |
| 1 | Corticosteroid [EPC] | 691 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 593 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 389 |
| 4 | Benzodiazepine [EPC] | 361 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 317 |
| 6 | Vitamin C [EPC] | 294 |
| 7 | Proton Pump Inhibitor [EPC] | 263 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 226 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 221 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 22 | 0.0320 |
| 1 | Provitamin D2 Compound [EPC] | 182 | 0.0061 |
| 2 | CD123 Interaction [EPC] | 3 | 0.0056 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 95 | 0.0049 |
| 4 | Plasma Volume Expander [EPC] | 10 | 0.0032 |
| 5 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 6 | Dopamine-2 Receptor Antagonist [EPC] | 21 | 0.0027 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 8 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 14 | 0.0024 |
| 9 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 8 | 0.0022 |